Polymorphism of carbon oxidation of drugs and clinical implications.
- 2 September 1978
- Vol. 2 (6138), 655-657
- https://doi.org/10.1136/bmj.2.6138.655
Abstract
Eight volunteers previously phenotyped for their ability to hydroxylate debrisoquine (four extensive metabolisers (EM), four poor metabolisers (PM) were investigated for their metabolic handling of guanoxan and phenacetin. All three drugs are oxidised at carbon centres. Oxidative dealkylation of phenacetin was determined by measuring the rate of formation of paracetamol. The EM subjects excreted mostly metabolites of guanoxan (mean 29% of dose), whereas the PM group excreted large amounts of unchanged drug (48% of dose). The rate of formation of paracetamol was noticeably slower in the PM group, and, when analysed by minimum estimates of apparent first-order rate constants, the difference between the two phenotypes was significant. Thus the hydroxylation defect shown for debrisoquine metabolism carries over to the oxidative metabolism of phenacetin and guanoxan. Some 5% of the population are genetically defective hydroxylators of drugs. Thus methods for evaluating the metabolism of new drugs in respect of usage and side effects need to be revised.Keywords
This publication has 10 references indexed in Scilit:
- Hypotensive response to debrisoquine and hydroxylation phenotypeLife Sciences, 1978
- Clinical consequences of polymorphic acetylation of basic drugsClinical Pharmacology & Therapeutics, 1977
- POLYMORPHIC HYDROXYLATION OF DEBRISOQUINE IN MANThe Lancet, 1977
- Disease and Acetylation PolymorphismClinical Pharmacokinetics, 1977
- Gas-liquid chromatographic electron capture determination of some monosubstituted guanido-containing drugsAnalytical Chemistry, 1975
- Genetic and environmental factors affecting drug response in man.1972
- The Metabolism and Excretion of Guanoxan in ManXenobiotica, 1972
- Selective Colorimetric Determination of AcetaminophenJournal of Pharmaceutical Sciences, 1971
- ACETOPHENETIDIN-INDUCED METHEMOGLOBINEMIAAnnals of the New York Academy of Sciences, 1968
- A KINETIC STUDY OF DRUG ELIMINATION: THE EXCRETION OF PARACETAMOL AND ITS METABOLITES IN MANMETABOLITES IN MANBritish Journal of Pharmacology and Chemotherapy, 1967